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Background. Sulfonylurea agents exert their physiologic
effects via binding to specific sulfonylurea receptors (SUR)
in adenosine triphosphate-sensitive potassium (KATP) chan-
nels. Mesangial cells express KATP and respond to sulfony-
lureas by altering glucose metabolism, elevating intracellular
calcium and contracting. A putative endogenous sulfonylurea,
a-endosulfine, has been demonstrated in diverse tissues and is
a member of the cyclic adenosine monophosphate (cAMP)-
regulated family of phosphoproteins. This study investigates
mesangial cell expression of ENSA, the gene encoding a-
endosulfine, and its regulation by glucose.
Methods. Expression of rat glomerular and mesangial ENSA
was examined by reverse transcription-polymerase chain re-
action (RT-PCR) and Northern analysis. In situ hybridization
studies were carried out to investigate the presence and distri-
bution of ENSA in kidney cortex. Expression of mesangial cell
a-endosulfine was studied by immunoblotting, immunofluores-
cence, and confocal microscopy.
Results. RT-PCR with gene-specific primers and Northern
blotting disclosed abundant expression of two major ENSA
transcripts at 2.4 kb and 1.2 kb in whole rat kidney, kidney
cortex, and mesangial cells. In situ hybridization of rat kid-
ney demonstrated renal ENSA expression, particularly within
glomeruli. Confocal microscopy revealed a diffusely granular,
cytosolic distribution of a-endosulfine. High glucose concen-
trations increased ENSA expression by 24 hours, an effect that
persisted for at least 10 days. Protein expression paralleled gene
expression.
Conclusion. ENSA and a-endosulfine are expressed in rat
glomeruli and mesangial cell and gene and protein expression
are up-regulated by a high glucose environment. a-Endosulfine
has potential roles as a regulator of metabolism and contractility
via mesangial cell KATP.
Receptors for sulfonylureas (SUR) have been de-
scribed in renal tissue [1, 2]. However, little is known
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about their possible functional and metabolic effects,
independently of the increased insulin secretion and
decreased glycemia induced by these compounds. In
previous work, we have demonstrated the specific bind-
ing of sulfonylureas (SULF) to mesangial cell membranes
as well as the SULF-induced mesangial cell contractility
and changes in glucose transport and extracellular matrix
metabolism [3].
Because of the SULF binding to mesangial cell mem-
branes, we subsequently postulated that the metabolic
effects of SULF were mediated by the interaction of
SULF with their receptors, as part of a mesangial adeno-
sine triphosphate (ATP)-regulatable K+ channel (KATP)
[4]. This led to the cloning of two rat mesangial KATP,
one comprised of the weak inwardly rectifying potassium
channel (Kir6.1) and the B isoform of the rat type 2 sul-
fonylurea receptor (SUR2B), and another as a unique
mesangial KATP [5]. The latter KATP represents the prod-
uct of two genes, one that encodes a truncated form of rat
SUR2B and a second that encodes Kir6.1, presumably
combining in prototypical fashion as a tetradimer (mc-
SUR2B:Kir6.1)4 [6, 7]. Mesangial KATP also function as
mediators of mesangial cell contraction. Upon exposure
to the sulfonylurea glibenclamide, calcium transients, and
vigorous contractions are induced in cultured mesangial
cells [5].
Given these observations, the relevance of an endoge-
nous mesangial SUR arises. However, there is a paucity
of information regarding the presence of endogenous lig-
ands for SUR, despite their ubiquity as KATP subunits,
which might mimic or antagonize the effects of exogenous
SULF. The possibility for the existence of endogenous
SUR-like compounds acting as physiologic ligands of
SUR was first realized following the isolation of a group of
phosphoprotein-related peptides from ovine and porcine
brain [8–10]. These compounds, termed “endosulfines,”
are present in two isoforms, a- and b-endosulfine. The
composition and structure of a-endosulfine, which is en-
coded by the gene ENSA, have been well characterized
[11, 12]. Gene expression for a-endosulfine is evident
in human pancreas, heart, muscle, and kidney [11–13].
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Recombinant a-endosulfine enhances pancreatic KATP
activity of insulin-secreting MIN6 and RINm5F b cell
lines, effects that are mediated by L-type calcium chan-
nels during conditions of membrane depolarization to
initiate hormonal secretion. Recombinant protein also
inhibits binding of SULF to membranous receptors and
SULF-induced cloned KATP currents in Syrian hamster
insulinoma cells [12].
Because a-endosulfine is a putative endogenous ligand
for mesangial KATP at its SUR-binding locus, we sought
to determine if a-endosulfine is expressed in glomeruli in
vivo and in mesangial cell tissue culture. In addition, we
explored the hypothesis that the ENSA gene and its gene
product were, in part, regulatable by the ambient glucose
concentration.
METHODS
Reagents
Nu-Serum was obtained from Becton Dickinson
Biosciences (Franklin Lakes, NJ, USA). Antibiotics,
Tween-20, bovine serum albumin (BSA), and morpho-
linopropanesulfonic acid-ethylenediaminetetraacetic
acid (EDTA)-sodium acetate (MESA) buffer were
purchased from Sigma-Aldrich Co. (St. Louis, MO,
USA). RPMI 1640 medium and RNA sizing ladders
were purchased from Life Technologies (Gaithersburg,
MD, USA). QuikHyb solution was obtained from
Stratagene (La Jolla, CA, USA). Titan One Tube reverse
transcription-polymerase chain reaction (RT-PCR)
kits were obtained from Roche Applied Science (In-
dianapolis, IN, USA). TOPO TA cloning kits and the
pCR2.1/TOPO vector were purchased from Invitrogen
(Carlsbad, CA, USA). Wizard DNA Miniprep kits
were obtained from Promega Corp. (Madison, WI,
USA). QiaQuick gel extraction kits were obtained from
Qiagen (Valencia, CA, USA). RNA STAT-60 reagent
was obtained from Tel-Test, Inc. (Friendswood, TX,
USA). Radioactive [a-32P] deoxycytidine triphosphate
(dCTP) (3000 Ci/mmol) was acquired from NEN Life
Science Products (Boston, MA, USA). Bicinchoninic
acid protein assay kits were obtained from Pierce Labs
(Rockford, IL, USA). Sodium dodecyl sulfate (SDS)
polyacrylamide gels (10%) were obtained from Bio-Rad
(Hercules, CA, USA). ECL Plus Western Blotting
Detection Reagents were purchased from Amersham
Pharmacia Biotech (Piscataway, NJ, USA).
Animals
Male Munich-Wistar rats weighing between 150 and
200 g were obtained from Charles River Laboratories
(Wilmington, MA, USA). Animals were housed in ac-
cordance with good practice guidelines established by
AALAC and the animal care facilities of Henry Ford
Table 1. Gene-specific polymerase chain reaction (PCR) primers
Primer Sequence
rENSA500 5′-ACCATGTCCCAGAAACAAGAAGAAGA-3′
BAMrENSA5 5′-GGATCCATGTCCCAGAAACAAGA-3′
rENSA300 5′-tcattcaacttggccacccgcaag-3′
Uppercase, forward primer; lowercase, reverse primer.
Hospital. Animals were fed standard rat chow (Ralston
Purina Co., St. Louis, MO, USA) and permitted free ac-
cess to food and water. Following isofluorane anesthe-
sia, retrograde perfusion of the kidneys with ice-cold
Hank’s balanced salt solution containing 3.2% dextran
T40 was carried out via a needle placed in the abdomi-
nal aorta below the renal arteries. Subsequently, kidneys
were removed and 160 glomeruli rapidly microdissected
for RNA isolation, as previously described [14].
Tissue culture
The cells used were the previously well-characterized
cloned rat mesangial cell line 16KC2 [4]. These are
spindle-shaped cells and form hillocks in nonconfluent
cultures. The cells stain positively for vimentin and a-
smooth muscle actin (a-SMA), but not for cytokeratin
or factor VIII. Cellular contraction occurs following ex-
posure to either angiotensin II or arginine vasopressin.
These cells also bear atrial natriuretic peptide (ANP) re-
ceptors and the Thy-1 antigen on their surfaces. 16KC2
cells were seeded at a density of 10,000 cells per cm2 and
cultured to varying levels of confluence in RPMI 1640
medium containing 5 mmol/L glucose, 20% Nu-Serum,
and antibiotics (100 U/mL penicillin and 100 lg/mL strep-
tomycin). Cultures incubated with 25 mmol/L mannitol
were included as osmotic controls.
Cloning of rat ENSA
One microgram of rat brain total RNA was used as
template in a one-tube RT-PCR reaction to amplify the
coding sequence of the rat a-endosulfine cDNA with
the primer pair BAMrENSA5 and rENSA300 (Table 1).
The BAMrENSA5 primer was designed to introduce a
BamH1 recognition site at the 5′-end of the a-endosulfine
coding sequence. The PCR-generated amplicon was gel-
purified for use as template in subsequent radiolabeling
reactions for northern analysis and in direct T-A sub-
cloning into pCR2.1/TOPO. The ENSA/pCR2.1/TOPO
plasmid was propagated in TOP10 bacteria for subse-
quent isolation as plasmid cDNA by EcoR1 and BamH1
digestion and gel purification. Inserts were ligated into
pGEM-3Z (Promega) or pGEX-6P-2 (Amersham Life
Sciences) to create, respectively, clones for in situ hy-
bridization and bacterial expression of recombinant pro-
tein. Sequences and orientation of clones were confirmed
by bi-directional automated fluorescent DNA sequencing
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(ABI Prism System) (Applied Biosystems, Foster City,
CA, USA). Sequence analyses and alignments were con-
ducted with MacVector version 6.0 software (Genetics
Computer Group, Inc., Madison, WI, USA) as previously
described [5].
Northern analysis
Total rat RNA was isolated from 16KC2 cells and from
whole kidney, kidney cortex, heart, and brain in RNA
STAT-60 to conduct Northern analyses [4, 5]. Twenty mi-
crogram aliquots of total RNA were fractionated over
0.41 mol/L formaldehyde gels at constant voltage (100 V)
and transferred to charged nylon membranes by capillary
action, then ultraviolet light-crosslinked and hybridized
at 68◦C in QuikHyb. Probe synthesis was carried out by
the random-priming method, in the presence of [a-32P]
dCTP and template ENSA cDNA generated in conven-
tional RT-PCR of rat brain total RNA with primers that
completely spanned the 366 bp ENSA coding region. Au-
toradiography was carried out for 12 to 72 hours at −70◦C
with intensifying screens. Digital acquisition of hybridiza-
tion signals in northern analysis was followed by quanti-
tation of signal intensities with image analysis software,
after appropriate background subtraction.
RT-PCR analysis of ENSA gene expression
Expression of the ENSA gene in tissues and 16KC2
cells was explored by RT-PCR. Primers rENSA500 and
rENSA300 were designed specifically to amplify the 366
bp coding sequence of the rat a-endosulfine cDNA. RT-
PCR was carried out on 1 lg of total RNA from 16KC2
cells or rat heart, kidney, or brain with a single tube
methodology. Amplicons were visualized on ethidium
bromide-stained gels. PCR-ready cDNA was prepared
from microdissected glomeruli.
In situ hybridization
Following construction of pGEM3zf/ENSA, which
contained the entire coding region of a-endosulfine,
T7 and SP6 DNA-dependent RNA polymerases were
used to generate a-35S-uridine triphosphate (UTP)-
radiolabeled riboprobes by in vitro transcription for in
situ hybridization studies of rat renal cortex. Six micron
cryostat sections were hybridized using the method of
Barnes et al [15]. Following hybridization, sections were
examined under bright-field microscopy.
Anti-a-endosulfine antibodies
To investigate protein expression two antibodies were
used. The first, obtained by rabbit immunization with
a synthetic peptide corresponding to the 9 carboxy-
terminal amino acids of a-endosulfine (gift of Dr. Angus
C. Nairn, Yale University, New Haven, CT, USA) was
used for immunoblotting studies. This antibody was not
suitable for immunofluorescence studies.
A second IgG antibody, obtained by rabbit immuniza-
tion with recombinant a-endosulfine, was used for im-
munofluorescence studies. Recombinant a-endosulfine
was expressed by Escherichia coli using a gluthathione-
S-transerase (GST) fusion system (Amersham) fol-
lowing the manufacturer’s recommendations. Briefly,
BL21-GOLD bacteria (Stratagene) were transfected
with the ENSA-containing plasmid pGEX-6P-2/ENSA,
propagated in enriched medium and induced with iso-
propylthiogalactoside (IPTG) to express recombinant
protein. Fusion protein was isolated by glutathione-
sepharose affinity column chromatography. Protein was
obtained after cleavage of the fusion protein with GST-
linked protease and analyzed by SDS-polyacrylamide gel
electrophoresis (PAGE).
Immunoblotting
Tissue culture monolayers were scraped into an ice-
cold buffer (pH 7.4) containing 20 mmol/L HEPES,
2 mmol/L EDTA, 250 mmol/L sucrose, 0.1 mmol/L
phenylmethylsulfonyl fluoride (PMSF), 1 mmol/L pep-
statin, and 1 mmol/L leupeptin, then homogenized im-
mediately with a glass dounce. Brain and kidney tissues
were snap-frozen in liquid nitrogen immediately after an-
imal sacrifice, pulverized in a liquid nitrogen-cooled mor-
tar, and similarly homogenized. Five microgram aliquots
of total protein were separated by 10% SDS-PAGE
and transferred to nitrocellulose membranes using a
semidry transfer system. Membranes were blocked in 5%
dry milk/0.1% Tween-20/1 × phosphate-buffered saline
(PBS) solution and incubated for 60 minutes at 25◦C with
rabbit antiserum (1:500 dilution) directed against the 9
carboxy-terminal amino acids of a-endosulfine. Subse-
quent detection of proteins was by chemiluminescence.
Uniform protein loading was confirmed by reversible to-
tal protein staining with Ponceau S (Sigma).
Immunofluorescence and confocal microscopy
Renal cortical samples of perfused kidneys were sagi-
tally cut in a Steadie-Riggs tissue slicer (Thomas Scien-
tific, Swedesboro, NJ, USA) and frozen in dry ice-cooled
isopentane. Five to 7 lm thick cryosections were incu-
bated with rabbit anti-a-endosulfine antibody while neg-
ative controls were exposed to this same antibody after
its preadsorption with excess recombinant a-endosulfine
protein. Fluoresceinated antirabbit IgG was used as sec-
ondary antibody.
Mesangial cells were seeded on chamber slides at
25,000 cells/chamber. Studies were carried out in 50%
confluent cultures. Following a 24-hour period of serum
starvation [0.5% fetal bovine serum (FBS)], cells were
fixed in 3.7% paraformaldehyde in PBS, permeabilized
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in 0.1% Tween-20, 1% BSA in PBS, then blocked with
normal goat serum in PBS (1:100 dilution). Cell lay-
ers were overlain with rabbit anti-a-endosulfine an-
tibody (1:100 dilution) while negative controls were
incubated with preimmune rabbit serum. As secondary
antibody, goat antirabbit IgG-Alexa Fluor 488 conjugate
(Molecular Probes, Eugene, OR, USA) was used. Slides
were mounted in ProLong Antifade (Molecular Probes)
prior to confocal microscopy, using our previously de-
scribed method of digital acquisition and reconstruction
[16].
Statistical analysis
In Northern analyses, results of control groups were
normalized to a value of 1.0 and data were expressed as
means ± SEM. Experimental groups were compared by
the unpaired t test.
RESULTS
Rat ENSAidentification
As brain is an abundant source of both endosulfine
isoforms, we cloned the rat a-endosulfine gene from this
tissue. Using gene-specific primers, we isolated and sub-
cloned the 366 bp coding sequence of rat ENSA and
verified its nucleotide sequence on both strands. The se-
quence bears more than 80% homology to the 19 kD
cyclic adenosine monophosphate (cAMP) phosphoregu-
lated protein termed ARPP-19 (Fig. 1).
Renal ENSA expression
In three independent studies by Northern analysis, we
hybridized full-length ENSA cDNA under stringent con-
ditions to whole rat kidney, dissected renal cortices and
mesangial cells (Fig. 2). Using whole rat heart and brain
as positive controls, we detected robust hybridization sig-
nals in normal rat kidney, with major transcripts appear-
ing at 1.2 and 2.4 kb, consistent with endosulfine gene
expression. Minor transcripts also appeared at 4.2 kb.
These transcripts also appeared in like fashion in brain.
In heart, however, the probe hybridized to a much lesser
degree than in positive control whole brain tissue, whole
kidney or renal cortex. As with heart, the dominant tran-
script in mesangial cells appeared at 2.4 kb, although 1.2
and 4.2 kb transcripts were also demonstrated.
Glomerular ENSA gene and a-endosulfine
protein expression
To demonstrate the glomerular participation in the
observed whole renal cortex ENSA expression, we ampli-
fied total RNA from the microdissected glomeruli of nor-
mal rats and compared these to mesangial cell products
in RT-PCR reactions with a primer pair that spanned the
0.36 kbp open reading frame of rat ENSA. In three sep-
arate studies, appropriately sized gene products in posi-
tive control brain and heart tissues, glomeruli and cloned
mesangial cells were demonstrated (Fig. 3). To more fully
document the presence of ENSA gene expression in nor-
mal rat kidney, we carried out in situ hybridization. In sec-
tions of rat cortex, using riboprobes transcribed from the
ENSA coding sequence, the sense probe revealed mini-
mal background signal, while the antisense probe local-
ized mainly to glomeruli (Fig. 4).
To demonstrate that the glomerular expression of
ENSA was associated with that of its encoded protein,
the presence and distribution of a-endosulfine was stud-
ied by immunofluorescence. In cryosections of normal re-
nal cortex, a rabbit polyclonal antibody generated against
the rat recombinant a-endosulfine protein revealed a-
endosulfine to be highly expressed in the mesangial re-
gions of glomeruli (Fig. 4). This reactivity was totally
blocked by preadsorption of the antibody with recom-
binant a-endosulfine.
Distribution of a-endosulfine in mesangial cells
To evidence the presence and cell distribution of a-
endosulfine in mesangial cells in culture, immunofluo-
rescent detection of this protein was carried out with
confocal laser microscopy. In subconfluent cultures,
a-endosulfine appeared as fine granules diffusely dis-
tributed over the entire cytoplasm (Fig. 5). Minimal back-
ground staining was observed in specimens processed
with preimmune serum (Fig. 5). A similar expression
and cytoplasmic distribution of a-endosulfine was also
demonstrated in primary cultures of rat mesangial cells
(data not shown).
Glucose regulation of a-endosulfine in mesangial cells
There is no known physiologic regulator of the ENSA
gene. Since the position of this gene was reported to
colocalize to the type 1 diabetes susceptibility locus
IDDM11 [11], we explored the possibility that this gene
was glucose-regulatable. Changes in mesangial ENSA ex-
pression in response to alterations of the glucose concen-
tration in the culture medium were studied in mesangial
cells exposed to 30 mmol/L glucose for 48 hours or main-
tained in 5 mmol/L glucose medium as controls. Total
RNA was harvested from 90% confluent cultures and
subjected to northern blotting for the ENSA message.
High glucose concentration induced a twofold ENSA
gene up-regulation (N = 4; 2.05 ± 0.02; P < 0.001) (Fig. 6).
This up-regulation persisted for 10 days in cells main-
tained in the high glucose medium. In addition, gene up-
regulation continued for 14 days even upon return of the
cells to 5 mmol/L glucose. Incubation with 25 mmol/L
mannitol did not induce significant changes in gene ex-
pression. By immunoblotting, a similar demonstration
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Fig. 1. Open reading frames of rat ENSA and ARPP-19 and peptide alignments of a-endosulfine and ARPP-19 proteins. The alignment of the
nucleotide sequences of the 339 bp coding region of ARPP-19 (GenBank Accession No. AJ005982) and the 366 bp ENSA gene (GenBank Accession
No. AJ005984), beginning twith their respective initiation codes (A). There is approximately 80% homology between the two genes. Anti-endosulfine
antibody generated against the 9 carboxy-terminal amino acids of the translated ENSA sequence was used in immunoblotting studies. The peptide
alignments of a-endosulfine and ARPP-19 proteins are also shown (B). The conserved protein kinase A (PKA) phosphorylation site of each peptide
is underlined. The target serines of ARPP-19 (S104) and a-endosulfine (Sl09) are denoted (∗).
of a-endosulfine overexpression during exposure to
high glucose concentration was shown. A 1.7-fold up-
regulation of the protein was observed in mesangial cells
similarly exposed to 30 mmol/L glucose in three indepen-
dent experiments (Fig. 6).
DISCUSSION
Endosulfines are members of a highly conserved and
emerging family of proteins termed the cAMP regu-
lated phosphoproteins (ARPP) [17, 18]. The a- and b-
endosulfines were identified as putative “endogenous
sulfonylurea-like” compounds that might serve as regu-
lators of endogenous KATP, whereas the identities of the
nonendosulfine members of this family, ARPP-16, -19,
and -21 and DARPP-32 were uncovered as components
of the mammalian brain neostriatum [19–24]. Presum-
ably, all of the ARPP represent substrates of phosphory-
lation by protein kinase A (PKA) and several have been
shown activatable via cAMP.
The a-endosulfine gene ENSA, also designated as
ARPP-19/e, is a type III ARE (adenylate uridylate-rich
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Fig. 2. Northern blot analysis for ENSA. Twenty microgram aliquots
of total RNA were extracted from rat tissues and mesangial cells, frac-
tionated over 0.41 mol/L formaldehyde gels, hybridized with a-32P-
readiolabedl full-length cDNA of ENSA, and washed at high stringency
prior to autoradiography. Major transcripts are detected at 1.2 and 2.4
kb in whole kidney, kidney cortex, mesangial cells (MC), and in positive
control brain and heart tissues.
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Fig. 3. Glomerular rat ENSA expression. Conventional reverse
transcription-polymerase chain reaction (RT-PCR) was carried out on
1 lg aliquots of total RNA obtained from rat tissues, mesangial cells,
and microdissected glomeruli for 30 cycles with ENSA gene-specific
primers. Fragments at the predicted size, 0.36 kbp, are noted (arrow)
and appear to the right of the DNA size marker in rat heart (H), brain
(B), mesangial cells (MC), and glomeruli (G). No amplicons of the ap-
propriate size appear in the negative control water (W) lane.
element)-containing mRNA, a group that includes a
functionally diverse group of proteins, including Gro,
cyclooxygenase-2 (COX-2), sodium bicarbonate trans-
porter (SLC4A7), cAMP-responsive element binding
protein (CREB), interleukin (IL)-2, and thromboplas-
tin [25]. ENSA shares 82% homology with ARPP-19
at the nucleotide level [12]. At the protein level, a-
endosulfine differs from ARPP-19 by possessing nonho-
mologous amino and carboxy termini, with a different
four amino acid extension at its C-terminal moiety [18].
a-Endosulfine is ubiquitously expressed, particularly
in brain, heart, pancreas, and kidney. In the brain, it has a
particularly high density in striatal neurons. In pancreas,
a-endosulfine has been recently localized to the cytosol
of RINT3 somatostatin-secreting d cells [26]. The present
study demonstrates that rat ENSA is identical to the hu-
man homologue. For the first time, it is also shown that
the renal expression of ENSA and its encoded protein
are primarily localized to glomeruli, particularly within
the mesangial compartment. Further, as for the pancre-
atic d cells, a-endosulfine is demonstrated to be a cytoso-
lic protein. Because of overlapping sequences of ENSA
with ARPP-16 and ARPP-19, there is the possibility that a
portion of hybridization signals may have emanated from
the presence of ARPP gene expression. However, pred-
icated upon further gene expression studies using RT-
PCR with ENSA-specific primers, we conclude that the
predominance of hybridization signal stems from ENSA
expression.
Little is known regarding the physiologic role of a-
endosulfine. The ARPP family of proteins demonstrates
a highly conserved core of 82 identical amino acids in all
vertebrates, which includes a PKA phosphorylation site
[18]. The high degree of conservation of this site suggests
that the regulation by cAMP-dependent phosphoryla-
tion is a fundamental mechanism of cell function, includ-
ing posttranscriptional control of gene expression growth
factor activity [27]. For example, the relative lack of a-
endosulfine protein in the cerebellar regions and frontal
cortex of Alzheimer’s disease and Down syndrome pa-
tients provides a clue to its critical role in neuronal func-
tion [28, 29]. However, ARPP proteins are without known
enzymatic activity. Available evidence does not suggest
that a-endosulfine would modulate signal transduction
as a protein phosphatase 1 inhibitor, like DARPP-32,
since cyclin-dependent kinase 5 phosphorylation of a-
endosulfine has not been demonstrated [30].
It was initially assumed that a-endosulfine could be an
autocrine or paracrine regulator. Insulin secretion from
insulinoma cell lines occurs after exposure to exogenous
a-endosulfine and is associated with L-type calcium chan-
nel activation after initial membrane depolarization [12,
13]. In addition, the site of action of a-endosulfine is the
same as that occupied by SURs because a-endosulfine in-
hibits glibenclamide-invoked currents in patch clamping
experiments with insulinoma cells [12]. However, ARPP
proteins possess characteristics common to intracellu-
lar regulatory molecules that alter the activities of en-
zymes involved in signal transduction [e.g., calmodulin
and the PKA inhibitor (Walsh inhibitor, PKI)] [18]. It
has been postulated that a-endosulfine does not mediate
its actions in an autocrine or paracrine fashion because
(1) treatment of pancreatic a cells with somatostatin
secretagogues fails to induce a-endosulfine release [26],
(2) KATP inhibition only occurs in high extracellular a-
endosulfine concentrations [12], (3) plasma a-endosulfine
levels are only at the picomolar range concentration [26],
and (4) as shown by us in mesangial cells, others have also
demonstrated that a-endosulfine is a particulate fraction-
associated cytosolic protein [26]. In consonance with this
postulate, nearly 90% of KATP are not localized to the
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Fig. 4. Identification of ENSA and a-
endosulfine in rat renal cortex. Sense and
antisense cDNA probes of ENSA were
radiolabeled by 35S-uridine triphosphate
(UTP) and applied to normal rat kidney
sections for detection by in situ hybridization.
A glomerulus is demonstrated in the section
exposed to the antisense probe (A) where
its margins are circumscribed by arrows.
Hybridization signal appears primarily
over the mesangial compartment. Minimal
background hybridization signal appears
in the tissue exposed to the sense probe
(B). Cryosections of normal rat renal cortex
were incubated with a rabbit polyclonal
antibody generated against rat recombinant
a-endosulfine protein. Fluoresceinated
antirabbit IgG was used as secondary
antibody. Results were obtained after
incubation with antiserum before (C) and
after (D) preadsorption of primary ntibody
with recombinant a-endosulfine (original
magnification ×63).
Fig. 5. Identification of a-endosulfine in mesangial cells. Antirecom-
binant a-endosulfine antibody (1:50 dilution) was overlain on cham-
ber slide cultures of mesangial cells following fixation as described in
the Methods section. Immunofluorescent detection of a-endosulfine by
goat antirabbit Alexa Fluor 488-conjugated secondary antibody was car-
ried out with confocal laser microscopy. Specific anti-endosulfine stain-
ing is demonstrated only in the cytosol of mesangial cells (A). Minimal
background staining is detected by incubation with rabbit preimmune
serum (B) (original magnification ×63).
plasmalemma, but to the endoplasmic reticulum, mito-
chondria, and secretory granules [31–34]. Consequently,
nearly 70% of all SUR binding is cytosolic [35], including
the SUR binding site of the b cell KATP which is on its
cytosolic aspect [36]. In the aggregate, these data favor
a-endosulfine as an intracellular regulator [26]. A recent
finding that ARPP-19 phosphorylation serves as a growth
regulator in nerve cones via nerve growth factor stabiliza-
tion of GAP-43 mRNA provides for the possibility that a-
endosulfine might serve a similar growth regulatory role
in mesangial cells [27].
This is the first demonstration of a new mesangial
receptor-ligand system with a potentially important role
in the pathogenesis of glomerular disease. Mesangial cells
become hypocontractile in a high glucose environment,
decreasing the presence of their F-actin cytoskeleton [16,
37]. If a-endosulfine increased under such stimulus and,
like SURs, induced membrane depolarization via intrin-
sic KATP, then cellular hypocontractility would be miti-
gated. This could prove important in diabetic glomerular
disease, by limiting expansion of the glomerular filtering
surface area and hence, hyperfiltration, in already hyper-
trophied glomeruli [38–41]. However, there is minimal
information regarding regulation of ENSA and a-
endosulfine expression. Only a single report describes dif-
ferential regulation of Kir6.2 and ENSA after high-dose
exposure of RINm5F cells to IL-1b[42]. From previous
observations that SURs increase glucose uptake in multi-
ple tissues, including mesangial cells [3, 43–45], we postu-
lated that ENSA might prove to be a glucose-regulatable
gene. In this study, it is shown that high glucose con-
centrations reproducibly elevated mesangial ENSA ex-
pression. In fact, this expression persisted for 10 to 14
days, despite normalization of glucose concentration. a-
Endosulfine expression also increased commensurately
after exposure to high glucose concentrations. These and
the observations by others, suggest that a-endosulfine
may influence the development of diabetic glomerular
injury via its potential actions as a regulator of mesangial
cell signal transduction, glucose uptake, and glomerular
filtration.
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Fig. 6. Glucose regulation of ENSA. Total RNAs from mesangial cells
were extracted and probed for ENSA with full-length cDNA in North-
ern analysis (top panel). Shown are data from cells cultured in 5 mmol/L
(lanes 1 and 3) or 30 mmol/L glucose (lanes 2 and 4). The 2.4 kb ENSA
transcript was increased by twofold over controls in cells incubated in
high glucose concentration (A). Uniformity of loading to total RNA is
verified by the uniformity of 18S bands from all samples (B). A represen-
tative experiment of a-endosulfine up-regulation by 30 mmol/L glucose
is shown (bottom panel). Fifty micrograms of mesangial cell lysate pro-
tein were analyzed by immunoblotting with antibody generated against
the 9 carboxy-terminal amino acids of a-endosulfine. Quantitative as-
sessment of results was obtained by image analysis (NIH Image, version
1.63) of digitized autoradiographs. An increase in immunoreacting pro-
tein is evident in cells exposed to an elevated glucose concentration.
CONCLUSION
We have provided an initial report that demonstrates
glomerular and mesangial cell gene and protein expres-
sion of ARPP-19/e, a-endosulfine. In addition, we have
shown inducibility of ENSA and a-endosulfine by high
glucose, an effect that is unexpectedly prolonged. a-
Endosulfine’s regulatory or counter-regulatory roles in
signal transduction, glucose transport, ion channel func-
tion, contractility, and extracellular matrix metabolism
each represents a potential avenue of inquiry and, as with
the other ARPP proteins, much remains to be learned.
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